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Abstract
Ovarian cytomegalovirus (CMV) infection is a rare finding reported in autopsy studies of
immunocompromised patients. We report the first case of bilateral CMV oophoritis diagnosed in
surgical resection specimens from a 63-year-old woman with metastatic brain lesions undergoing
whole brain radiation and steroid treatment. The ovarian involvement of CMV infection was an
incidental finding during the colectomy and bilateral salpingo-oophorectomy procedure for
gastrointestinal bleeding and presumed ovarian metastases. In contrast to the prevailing dogma, a
review of the literature found similar prevalence of pre-menopausal and post-menopausal cases.
While age related vasculopathy was thought to be the prevailing mechanism for CMV oophoritis,
the observation of an inflammation mediated microthrombosis in our case provides a plausible age
independent mechanism suggesting that both restrictive and obstructive vascular changes can be
involved in the pathogenesis of CMV oophoritis. To avoid misdiagnosis, both pathologists and
clinicians should recognize ovarian involvement by CMV as a possibility in the
immunocompromised patient.
Background
Cytomegalovirus (CMV) oophoritis has been rarely
reported in the literature [1-10]. It usually occurs as an
incidental finding in immunocompromised patients,
either as part of a disseminated infection or as an isolated
condition. We report here the first case of bilateral CMV
oophoritis diagnosed in surgical resection specimens
from a 63-year-old woman with metastatic brain lesions
undergoing whole brain radiation and steroid treatment.
Case presentation
The patient was a 63-year-old woman with a history of
lung cancer who presented with a three-week history of
confusion and homonymous hemianopsia. On CT scan,
she was found to have multiple hypodense cerebral
lesions that were presumed to be metastases. She subse-
quently received whole brain radiation and steroids. Her
post treatment course was complicated by heavy gastroin-
testinal bleeding from a duodenal ulcer. Three weeks sub-
sequent to initiation of therapy, she developed a colonic
perforation and underwent emergent laparotomy. The
ovaries were also noted to be enlarged bilaterally and
thought to be involved by metastatic disease. The patient
underwent a left hemicolectomy and bilateral salpingo-
oophorectomy. However, the patient's gastrointestinal
bleeding persisted, and she passed away four days after
surgery. A post-mortem examination was not performed.
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Pathological findings
On gross examination, both ovaries were edematous and
showed cortical hemorrhage. The left ovary also demon-
strated a 2.5 cm homogeneous calcific white nodule.
Microscopic examination revealed extensive cortical coag-
ulative necrosis within the areas of hemorrhage (Fig. 1A).
In these hemorrhagic areas, there was a mixed inflamma-
tory infiltrate accompanied by sheets and clusters of
enlarged stromal and endothelial cells with abundant
amphophilic cytoplasm, large intranuclear inclusions that
formed characteristic perinuclear halos, and variable
intracytoplasmic inclusions. Fibrin thrombi were identi-
fied within or adjacent to the lesional areas (Fig. 1B–C).
An immunohistochemical stain for cytomegalovirus pro-
tein (clone DDG9+CCH2, dilution 1:50, Dako Cytoma-
tion) highlighted massive infiltration of ovarian cortex by
CMV infected cells (Fig. 2A).
There were also prominent post-menopausal restrictive
vascular changes throughout the surrounding ovary, con-
sisting of markedly thickened arterial walls with deposi-
tion of eosinophilic collagenous material (Fig. 3). The left
ovary also contained a 2.5 cm ovarian fibroma.
The resected segment of colon demonstrated diverticuli-
tis, including one ruptured diverticulum with a surround-
ing serositis. The fallopian tubes demonstrated an acute
salpingitis. Immunohistochemical stains for CMV high-
lighted scattered positive cells in the lamina propria as
well as in the serosa of the colon near the perforation (Fig.
2B).
Discussion
Previously, there have been 10 reports of 12 cases of CMV
oophoritis in the English literature [1-10]. The main clin-
ical features of all cases including the current case are sum-
marized in Table 1. The mean age at presentation was 44.7
(range: 11–67), and 7/13 (53.8%) were post-menopausal.
(A) Massive infiltration of ovarian cortex by CMV infected  cells and (B) Scattered CMV positive cells in the colon  (Immunoperoxidase, original magnification ×400) Figure 2
(A) Massive infiltration of ovarian cortex by CMV infected 
cells and (B) Scattered CMV positive cells in the colon 
(Immunoperoxidase, original magnification ×400).
(A) Areas of hemorrhage with extensive coagulative necrosis  (arrows) (H&E, whole slide scan, equivalent to magnification  of approximately ×12) Figure 1
(A) Areas of hemorrhage with extensive coagulative necrosis 
(arrows) (H&E, whole slide scan, equivalent to magnification 
of approximately ×12). (B) Vasculitis and (C) Fibrin micro-
thrombus (H&E, original magnifications ×400).Diagnostic Pathology 2007, 2:50 http://www.diagnosticpathology.org/content/2/1/50
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All patients showed evidence of immunosuppression.
Eight of thirteen (61.5%) had pre- or post-mortem docu-
mentation of systemic involvement by CMV and two of
these cases (2/8, 25%) received ganciclovir as treatment.
Five of thirteen (38.5%) had a clinical or gross presenta-
tion of mass lesion (s).
Originally described by Subietas et al in 1977 [8], bilateral
CMV oophoritis is a rare pathologic finding that is usually
associated with a systemic infection. An underlying malig-
nancy or immunosuppressive status is almost always
present and steroid therapy has been shown to be a strong
risk factor for CMV reactivation in both groups [5,8,11], as
it is in our current case. It has been suggested that previ-
ously reported isolated CMV oophoritis might represent
sampling error [7]. Indeed, the presence of a duodenal
ulcer also raises the possibility that this incidental finding
of bilateral oophoritis might have been part of a general-
ized CMV infection. However, there was no serologic or
post-mortem documentation of systemic disease in this
case.
It is worth noting that only slightly over half of the
reported CMV oophoritis cases were from post-menopau-
sal women [1-3,5,9,10], even though it was historically
thought to be a disease of post-menopausal patients [4,6-
8]. This revised age distribution has some implications
with regards to pathogenesis. The predilection of CMV for
endothelial cells is thought to be important in the patho-
genesis of CMV oophoritis. Initially, an explanation of the
predilection of CMV oophoritis towards the post meno-
pausal age was that the obstruction of blood flow second-
ary to age related restrictive vascular changes seen in post-
menopausal women was a critical factor for localizing the
infection to the ovary, thus allowing progression of dis-
ease [3,8,10]. The ovaries in our current case did indeed
demonstrate prominent age related vascular changes in
the post-menopausal ovaries, including eosinophilic col-
lagen deposition and vessel wall thickening leading to
narrowed lumina.
However, the subsequent inflammatory response and sec-
ondary vasculitis with microthrombi seen in our case also
likely perpetuated this vascular restriction. CMV infected
endothelial cells have been observed in the small vessels
of the cortex in almost every reported case of CMV oopho-
ritis, in both pre- and post-menopausal women (1–10).
Generalized endothelial cell involvement in small vessels
is a common phenomenon in multi-organ CMV disease
[3]. Iwasaki et al. suggested that tissue involvement might
begin with endothelial cell infection after the virus enters
the ovary through bloodstream. The infected endothelial
cells lining the vascular wall or those "desquamated" into
the vascular spaces might have caused vascular obstruc-
tion, resulting in a localized vasculitis, thrombosis and
secondary distal coagulative necrosis.
Additionally, mounting evidence suggests that CMV virus
particles can directly initiate coagulation cascade and
thrombin production [12,13]. In vitro studies suggest the
activation of coagulation system mediated by tissue factor
expression on the surface of infected endothelial cells, in
combination with the essential phospholipids and tissue
factor activity on modified CMV envelope [12,13]. In vivo
studies demonstrate CMV-induced high factor VIII con-
centration and increased von Willebrand factor levels,
suggesting a procoagulant response [14,15]. Numerous
cases of acute thrombosis during CMV infection have
been reported, manifested as either disseminated intravas-
cular coagulation or localized organ specific infarct
[12,16].
The observation of multiple small vessel fibrin throm-
boemboli as seen in our case was not mentioned as a con-
tributing factor in any of the previously reported CMV
oophoritis cases. In fact, the lack of microthrombi was
noted by Subietas et al [8] and actually considered one of
the arguments against a virally induced vasculopathy.
However, our case provides evidence for an alternate
pathway for perpetuation of CMV infection in the ovary
that does not require post menopausal restrictive vascular
changes, thus providing one possible explanation for the
nearly equal distribution between pre- and post- meno-
pausal patients [1-3,5,9,10].
The vast majority of reported cases were missed during the
patients' lifetimes, except one case that was diagnosed in
a patient who underwent surgical procedure for CMV-
associated pelvic infectious disease and the ovarian
Prominent restrictive vascular changes (H&E, original magni- fications ×100) Figure 3
Prominent restrictive vascular changes (H&E, original magni-
fications ×100).Diagnostic Pathology 2007, 2:50 http://www.diagnosticpathology.org/content/2/1/50
Page 4 of 5
(page number not for citation purposes)
involvement was limited to the left ovary [9]. Our current
case is the first reported case of bilateral CMV oophoritis
diagnosed in a surgical specimen for a patient with non-
gynecological disorders. Subietas et al [8] and LiVolsi and
Merino [4] have previously emphasized the diagnostic
challenge of CMV oophoritis both clinically and patho-
logically. Difficulties in diagnosis arise from inadequate
sampling of macroscopically normal-sized ovaries, the
assumption that enlarged ovaries are involved by meta-
static disease, particularly when there is a known concur-
rent malignancy, and the similar microscopic appearance
of massive CMV infection to a malignant infiltrate. The
ovarian changes in our case were initially presumed to be
metastatic tumors by the surgeon. In fact, 38.5% of previ-
ously reported cases did indeed grossly mimic tumors or
mass lesions. Despite the lack of direct symptomatology
from the oophoritis, all reported cases demonstrated cor-
tical destruction and extensive histologic involvement by
CMV infected cells. The cells enlarged by both nuclear and
cytoplasmic inclusions may mimic an anaplastic carci-
noma, melanoma or a large cell lymphoma, and thus
awareness of the entity of CMV oophoritis is tantamount
to its recognition [3,8].
It is unclear whether ovarian CMV infection is a manifes-
tation of systemic infection or actually the primary site of
involvement. The putative vascular/restrictive pathogene-
sis model described above along with cases of isolated
CMV oophoritis [5,7] make the ovaries plausible candi-
dates to serve as CMV reservoirs. Additionally, CMV DNA
has been identified in arterial wall smooth muscle cells in
both seropositive and seronegative healthy individuals
[17]. However, the fact remains that most CMV oophoritis
cases have been associated with concurrent multiorgan
involvement, making it difficult to make any conclusive
statements regarding CMV manifestation in the ovary [1-
3,6,8,10]. Furthermore, data on the role of the ovary in
CMV latency is sparse [17-20].
Antiviral agents such as ganciclovir are the treatment of
choice for CMV infection. In the two cases that had pre-
mortem documentation of systemic CMV infection and
were treated with ganciclovir, post-mortem studies
revealed continuing systemic infection in one case [2] and
an isolated CMV oophoritis in the other case [6] (Table 1).
The residual isolated CMV oophoritis after ganciclovir
treatment illustrated the resistance to ganciclovir in the
ovaries. It has been postulated that decreased blood flow
in the postmenopausal ovary might reduce the ganciclovir
level in ovarian tissue and help sequester CMV from anti-
viral treatment [6].
Hence in summary, CMV oophoritis is a rare occurrence
that may affect both post- and pre-menopausal women
who are immunocompromised. Observations of this case
suggest that vascular changes, both native (restrictive) and
Table 1: Main clinical features of reported CMV oophoritis cases in the English literature
First Author Age Menopausal 
Status
Primary 
Diagnosis
Prior 
Immunosuppressive 
Treatment/State
Documented 
Systemic CMV 
infection
Treatment 
of CMV
Presentatation 
as Mass lesion
Diagnostic 
Material
Subietas 
(1977)
62 Post-menopausal Astrocytoma Radiation Yes (post-mortem) No No Autopsy
Subietas 
(1977)
40 Post-menopausal Hodgkin 
Lymphoma,
Chemotherapy, 
Steroids, Radiation
Yes (post-mortem) No No Autopsy
Subietas 
(1977)
67 Post-menopausal Breast CA Testosterone, 
Steroids
No No No Autopsy
Evans (1978) 37 Pre-menopausal SLE Steroids Yes (post-mortem) No Yes Autopsy
LiVolsi (1979) 61 Post-menopausal Lymphoma Chemotherapy, 
Steroids
Yes (post-mortem) No No Autopsy
Iwasaki (1988) 11 Pre-pubertal ALL Chemotherapy, 
Steroids
Yes (pre-mortem) N/A No Autopsy
Williams 
(1989)
40 Pre-menopausal Cholangio-CA Liver Transplant Yes (post-mortem) No Yes Autopsy
Familiari 
(1990)
33 Pre-menopausal AIDS Anti-retrovirals Yes (pre-mortem) Yes No Autopsy
Sharma (1994) 50 Post-menopausal Breast CA Autologous BMT No No No Autopsy
Wales (1996) 31 Pre-menopausal HIV, PID Anti-retrovirals, No No Yes (limited to 
left ovary)
Surgical 
Resection
Nieto (1999) 50 Post-menopausal Breast CA Allogenic BMT Yes (pre-mortem) 
*
Yes No Autopsy
Manfredi 
(2000)
36 Pre-menopausal AIDS Presumed CNS 
Toxoplasmosis & 
Lymphoma
No No Yes Autopsy
Current Case 
(2007)
63 Post-menopausal Lung CA Radiation, Steroids No No Yes Surgical 
Resection
ALL: acute lymphocytic leukemia; BMT: bone marrow transplantation; CA: carcinoma; CNS: central nervous system; PID: pelvic infectious disease; SLE: 
systemic lupus erythematosus; N/A: not available; *: pre-mortem systemic CMV infection but post-mortem isolated oophoritisPublish with BioMed Central    and   every 
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virally induced (obstructive), represent viable pathoge-
netic mechanisms. Despite the lack of direct symptoma-
tology, CMV oophoritis often presents as a mass lesion,
and characteristically shows extensive cortical destruction
and a high burden of virally infected cells. However, it is
still unclear whether CMV reactivation in the ovaries is
only a component of systemic spread or the actual pri-
mary site of origin of disease. To avoid misdiagnosis or
underdiagnosis, both pathologists and clinicians should
recognize ovarian involvement by CMV as a possibility in
the immunocompromised patient.
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